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Abstract
Period2 (PER2), a core circadian gene, not only modulates circadian rhythm but also may play an important role
in other biological processes including pathways involved in the proliferation and apoptosis of tumor cells. In this
study, we investigated the mechanism by which downregulated expression of PER2 promotes apoptosis of wild-type
TP53 human glioma U343 cells exposed to X-rays. U343 cells were irradiated with 6mV 10Gy X-ray irradiation after
infection with shRNA lentivirus to reduce expression of PER2, and then analyzed by several methods such as SCGE
analysis, flow cytometry, RT-PCR, and western blotting. Compared with controls, U343 cells expressing low levels of
PER2 showed serious DNA damage when exposed to X-ray irradiation in SCGE analysis (P<0.05), and higher
death rates in flow cytometry assay (P<0.05). RT-PCR and western blot analysis both revealed decreased
expression of ATM and TP53, which regulate DNA damage and repair via the ATM-TP53 pathway, and an increased
expression of C-MYC, which is related to cell apoptosis. Thus, our research suggests that PER2 may play an
important role in tumor radiotherapy, which is attributable to enhanced ATM-TP53 signaling and pro-apoptotic
processes. These findings provide a new target for the clinical treatment of glioma, and a reliable basis for post-
radiation therapy and gene therapy for glioma and other cancers.
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Introduction
The clinical management of malignant glioma is the most difficult
faced by the practicing neurologist. Patients have a very poor
prognosis, largely because of the paucity of druggable targets amenable
to therapeutic intervention. However, recent progress at the molecular
level has identified candidate targets, many of which have potential to
become future treatment options.
The Period2 (PER2) gene is an indispensable component of the
mammalian circadian clock [1]. In 2002, the murine PER2 gene was
reported to play an important role in tumorigenesis. A higher
incidence of tumor development was observed in PER2-deficient mice
than in wild-type mice [2]. In addition, clear differences in PER2
expression are evident in tumor tissue and non-involved peripheral
tissues [3-7]. Elsewhere, overexpression and/or or mutations in the
PER2 gene have been reported to correlate with enhanced tumor
growth in breast cancer, colon cancer and lymphoma, corresponding
with altered expression of TP53 and the oncogenes BCLxl, BCL-2,
cyclinB1, cyclin D, cyclin E and C-MYC [8-15]. PER2 has also been
linked with DNA damage response pathways [16]. X-ray-induced
DNA damage in tumor cell lines with mutated PER2 exhibited
increased sensitivity to damage affecting cell proliferation, apoptosis,
and the TP53 pathway [17-19].
While it is evident that PER2 is critical to cell proliferation,
apoptosis and the TP53 pathway in neoplasia, the mechanism remains
poorly understood. Based upon previous studies, we have examined
the role of PER2 in the cellular response to X-ray-induced DNA
damage in the human glioma U343 cell model. RNA interference
technology was used to downregulate the expression of PER2. We
observed that U343 cells with low-level expression of PER2 exposed to
low dose X-ray irradiation exhibited serious DNA damage and a
enhanced death rate. Our data indicate that PER2 interacts with the
TP53 pathway and contributes to increased TP53 activity, rescuing
DNA-damaged cells from TP53-mediated apoptosis.
Material and Methods
Cell lines and reagents
The U343 glioma cell line was purchased from Ji Ni Biotechnology
Co. Ltd. (Guangzhou, China). Cells were maintained according to the
supplier’s directions and guidelines, and were cultivated at 37°C in
100% Rh 5% CO2/95% air atmosphere. ShRNA-PER2 lentivirus was
obtained from the Genechem Chemical Technology Co. Ltd.
(Shanghai, China). Oligonucleotide primer and probe sequences were
designed and provided by Sangon Biotech Co. Ltd. (Shanghai, China).
The Annexin V-EGFP Apoptosis Detection kit (KeyGEN
Biotechnology, Najing,China), Comet Assay for DNA Damage
Detection Kit (KeyGEN Biotechnology, China), puromycin (Solarbio
Technology Co. Ltd., China), and Maxima SYBR Green Qpcr Master
Mix (Fermentas, USA) were used according to the manufacturers’
instructions.
Transfection with shRNA lentivirus
The expression of PER2 was regulated using lentiviral transfection
of shRNA. U343 glioma cells were stably transformed with shRNA-
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PER2 and shRNA-control constructs according to the manufacturers’
protocol. U343 cells were plated in 6-well plates at a density of 2 × 104
cells/well in RPMI-1640 medium (Gibco, USA) and allowed to attach
for 18 h prior to transfection with shRNA lentivirus vectors. Cells were
permitted to integrate for 24 h after infection. Puromycin (3 ug/ml)
was added to select cells with integrated retrovirus and stable cell lines
were established after one week.Interference sequence of shRNA-PER2
are showed in Table 1.
Sense
strand
5'CCGGGCCAGAGTCCAGATACCTTTACTCGAGTAAAGG
TATCTGGACTCTGGCTTTTTG 3'
Antisense
strand
5'AATTCAAAAAGCCAGAGTCCAGATACCTTTACTCGAG
TAAAGGTATCTGGACTCTGGC 3'
Table 1: Interference sequence of shRNA-PER2.
X-ray irradiation
Stably-transfected glioma U343 cells were exposed to 124 cGy/min,
an exposure field of 25 × 25 cm2 and spacing of 80 cm, and an
accumulated dose of 10 Gy X-Rays (Varian Medical Systems Inc.,
California, USA).
Comet-FISH assay
The alkaline comet assay was performed following the standard
protocol of McKelvey-Martin et al. [20-22]. U343 glioma cells were
harvested and washed twice with phosphate buffered saline (PBS) and
mixed with 0.7% low-melting point agarose. An agarose gel sandwich
was prepared comprising of a base layer 0.5% of standard agarose and
a second layer of 0.7% low-melting point agarose with cells, and
overlaid with 0.7% low-melting point agarose to a depth of 0.5 mm.
The assay was incubated at 4°C in a high humidity environment for 30
min. Gels were immersed in alkaline lysis solution (90% lysis buffer
pH10 and 10% DMSO) and maintained in the dark for 2 h at 4°C. Gels
were briefly rinsed with PBS, equilibrated in 300 mM NaOH and 1
mM EDTA (pH13) for 40 minutes, and then subjected to 100 mA at 25
mV for 30 min. Gels were stained with propidium iodide, and DNA
comet tails visualized with a fluorescent microscope at an excitation
wavelength of 530 nm and emission wavelength of 620 nm.
Apoptosis assay
U343 human glioma cells were harvested using trypsin-EDTA,
resuspended to a concentration of 1 × 106 cells/ mL and stained with 5
μg Annexin-V-EGFP (for apoptosis) and 5 μg propidium iodide (for
ds-DNA) for 5 min at 4°C. Cells were analyzed using a flow cytometer
(BD Bioscience, USA) (excitation 488 nm; emission 525 nm (GFP) and
620 nm (PI).
Real-time PCR
Gene expression was quantified using real-time PCR analysis and
SYBR Green (Fermentas, USA). Total RNA was extracted from U343
cells with Trizol and reverse-transcribed into cDNA using RevertAid
First Strand cDNA Synthesis (Fermentas, USA). Samples were
analyzed in triplicate using a CXF96 Real-time PCR System (Bio-Rad,
Hercules, Ca, USA). A total of 500 ng of sample cDNA was subjected
to the following: 2 min at 50°C (annealing), 10 sec at 95°C (melting),
followed by 40 cycles of 15 sec at 95°Cand 30 sec at 56°C and 30 sec
extension at 72°C. Primers and probes were designed to hybridize with
ATM, TP53, C-MYC and PER2, as shown in Table 2.
Per 2 forward 5' CCCTGGTGTCTGGGAAGAT 3'
 reverse 5' GGAGGTGAAACTGTGGAACA 3'
ATM forward 5' TGTGACTTTTCAGGGGATTTG 3'
 reverse 5' ATAGGAATCAGGGCTTTTGGA 3'
P53 forward 5' CTCCTCAGCATCTTATCCGAGT 3'
 reverse 5' GCTGTTCCGTCCCAGTAGATTA 3'
c-myc forward 5' CCTCCACTCGGAAGGACTATC 3'
 reverse 5' TGTTCGCCTGACATTCTC 3'
β-actin forward 5' TGACGTGGACATCCGCAAAG 3'
 reverse 5' CTGGAAGGTGGACAGCGAGG 3'
Table 2: Primers and probes of ATM, TP53, C-MYC and PER2.
Western blotting
U343 glioma cells were harvested and total protein was extracted at
24 h after X-ray irradiation. Isolated proteins (40-60 mg) were
separated using SDS–PAGE, and transferred to nitrocellulose
membranes (Millipore, USA). Non-specific binding sites were blocked
with albumin and membranes probed with antibodies specific for
ATM, PER2, and C-MYC (Abcam, USA), TP53 (Proteintech, USA), or
β-actin (TransGen Biotechnology, China). Each assay was repeated at
least three times. Images and relative expression levels of target genes
were captured and quantified using Gel-Pro analyzer (Media
Cybernetics, USA).
Statistical Analysis
Data were analyzed where relevant using univariate analysis of
variance using SPSS version 11.0 (IBM Corporation, USA). Statistical
significance was accepted when P<0.05.
Results
Expression of PER2 in U343 glioma cells
Quantitative real-time PCR (qRT-PCR) and western blotting were
applied to assay PER2 expression at the RNA and protein levels,
respectively. Both RNA and immunoreactive protein were notably
reduced in U343 cells transfected with shRNA-PER2 relative to
shRNA-transfected control U343 cells (P<0.05; n=3) (Figure 1). The
expression level of PER2 mRNA was reproducibly reduced by more
than 70% in shRNA-PER2 cells (Figure 1A). Cells transfected with
shRNA-PER2 also expressed reduced PER2 protein levels compared
with control cells (Figure 1B).
Having demonstrated that lentiviral mediated RNA interference
technology was an effective inhibitor of PER2 expression, subsequent
experiments utilized this technology to examine the role of PER2 in
glioma cells subjected to low dose X-ray irradiation.
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Figure 1: Expression of PER2 mRNA and PER2 protein in U343
human glioma cell lines; A) U343 cells expressing shRNA-control
and shRNA-PER2 were detected by real-time PCR; B) Total cellular
protein was isolated from U343 glioma cells and 40-60 µg was
separated electrophoretically, transferred to nitrocellulose and
subjected to western blot analysis with antibodies directed against
the PER2 proteins. U343 cells were cultivated in vitro under
standard conditions.
X-ray irradiation attenuates PER2 expression in U343 glioma
cells
This experiment is intended to study the role of PER2 in the
apoptosis mechanism which is induced by X-ray irradiation. Prior to
this, we should to verify whether there was a relationship between
PER2 and X-ray radiation. We measured the expression of PER2 before
and after irradiation. PER2 expression was observed to decrease, both
at the mRNA level (qRT-PCR) and at the protein level (western blot)
(Figures 2A and 2B).
Figure 2: Effect of X-ray irradiation on the expression of PER2 in
U343 human glioma tumor cells; A) Relative mRNA level of PER2
in U343 cells transfected with shRNA-control or shRNA-PER2 were
measured by qRT-PCR; B) Total cellular protein was isolated from
U343 human glioma cells before and after exposure to X-ray
irradiation, then 40-60 µg total cellular protein was
electrophoretically separated, transferred to nitrocellulose and
subjected to western blot analysis using antibodies directed against
PER2 protein. β-actin was used a loading control.
Downregulation of PER2 enhances radiosensitivity and DNA
damage in U343 glioma cells
After exposure to 10 Gy of X-rays, U343 cells were selected with
puromycin for 7 days prior to analysis for DNA damage. Single cell gel
electrophoresis (SCGE) revealed the presence of differential DNA
damage. We noted DNA tailing was more prominent in cells
transfected with shRNA-PER2: the tail was eight times longer than the
group transfected with shRNA-control, suggesting decreased DNA
repair capacity in the shRNA-PER2 group (P<0.05; n=3) (Figure 3A
and 3B). These data indicated that the downregulation of PER2
increased glioma cell sensitivity to ionizing radiation, resulting in
increased DNA damage. The observed increase in DNA was significant
(P<0.05).
Figure 3: Single-cell gel electrophoresis (SCGE) analysis of X-ray (10Gy)-induced DNA damage in U343 cells; A) Fluorescence microscopy was
used to observe DNA tails in U343 cells transfected with shRNA-control and shRNA-PER2 with a specific multiple (10 × 20); B) U343 cells
were quantitated for Olive tail moment after exposure to 10 Gy X-ray irradiation. U343 glioma cells transfected with shRNA-control (0.644)
and shRNA-PER2 (5.301). This response was statistically significant (P<0.05; n=3).
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Downregulation of PER2 increases apoptosis in X-ray-
irradiated U343 glioma cells
To determine the possible effects of irradiation on the apoptosis of
glioma cells, U343 cells were double-stained with Annexin V-EGFP
and propidium iodide and analyzed using flow cytometry. In shRNA-
control-transfected U343 cells, 1.81% of the population was double-
positive for EGFP and PI, indicative of apoptosis. In contrast, U343
glioma cells expressing PER2 (transfected with shRNA-PER2) were
found to be 9.98% double-positive i.e. apoptotic (Figures 4A and 4B).
A similar situation was also observed in the double-staining cells by
epifluorescent microscopy, which confirmed double-staining cells were
apoptotic. (Figure 4C). These data suggest that downregulation of
PER2 is associated with a significant increase in apoptosis of the U343
cell population after exposure to X-ray ionizing radiation.
Figure 4: X-ray irradiation increases apoptosis in U343 glioma cells
after downregulation of PER2; A and B)U343 cells were transfected
with shRNA-control or shRNA-PER2 and selected for 7 days with
puromycin. Viable U343-shRNA-PER2 and U343-shRNA-control
populations were subjected to 10 Gy X-ray irradiation, and then
analyzed using flow cytometry. Double-stained EGFP/PI signals
were indicative of apoptosis; single PI-positive cells were necrotic;
single EGFP-positive cells were early apoptotic cells; C)
Epifluorescent microscopy of shRNA-control or shRNA-PER2 U343
glioma cells. Red (PI) fluorescence: mitochondria without intact
membrane potential; Green (Annexin V-EGFP) fluorescence:
phosphatidylserine (apoptotic cells).
Downregulation of PER2 reduces the expression of ATM and
TP53 but increases the expression of C-MYC in X-ray-
irradiated U343 glioma cells
Because our data suggested that PER2 protected U343 glioma cells
from programmed cell death, we subsequently examined the
expression of genes known to be important in DNA damage repair,
programmed cell death and proliferation, ATM, TP53, and C-MYC.
The expression of ATM and TP53 were found to be significantly
downregulated in U343 glioma cells after exposure to 10 Gy X-
irradiation. In contrast, the expression of the oncogene C-MYC was
increased in irradiated shRNA-PER2 U343 cells. Changes in mRNA
expression were found to correlate with similar changes in
immunoreactive proteins detected by western analysis (Figure 5A and
5B).
Figure 5: Effect of sh-RNA-PER2 on ATM, TP53 and C-MYC
mRNA and protein expression in U343 human glioma tumor cell
lines following irradiation; A) Relative mRNA levels were
determined by qRT-PCR; Data are expressed as ΔΔCT relative to
control; B) Total U343 glioma cell extracts were examined by
quantitative western blotting at 24 h after exposure to 10 Gy X-ray
irradiation; Antibodies were specific for ATM, TP53 and C-MYC.
Discussion
In recent years, research of the core clock circadian gene PER2 has
revealed its contribution to the pathology of diseases such as liver
cancer, breast cancer, colon cancer, lymphoma, and glioma. We have
investigated the role of PER2 in glioma. Evidence from initial research
implicated PER2 as a regulator of the circadian clock [14,23-25]; more
recently evidence has expanded on the function of PER2 function to
include the promotion of apoptosis in cancer [9,11]. We hypothesized
that PER2 is also a tumor suppressor gene.
Experimental evidence from our previous studies indicated that the
expression of PER1 and PER2 closely correlates with the incidence and
development of glioma. Moreover, biological rhythm has also become
an important prognostic indicator of survival of glioma patients [6].
However, our data from C6 glioma cells studied in vitro also indicated
its involvement. Following administration of radiation at different time
points, rhythm points expressing high levels of PER2 showed a death
rate significantly higher than other points. C6 cells transfected with
plasmid pcDNA3.1 (+) PER2 were mostly arrested at G2/M phase,
which downregulated proliferation and increased apoptosis of glioma
cells. In addition, we detected upregulation of PCNA expression
following downregulation of PER2, which further verified that PER2
and PCNA are both closely related to the degree of differentiation of
glioma. All of the above data suggested that PER2 plays an important
role in promoting apoptosis of glioma cancer cells [20]. These findings
are consistent with our data in human glioma cancer specimens [6].
As for the specific mechanisms, apoptosis was induced by X-ray
after DNA damage. When DNA damage occurs, it continues to activate
several checkpoints such as ATM/ATR, CHK1/2, and so on [21-22].
Then, TP53, an important protein in the regulation of DNA damage
and repair and the cell cycle also is activated [26-28], which results in
the arrest of the cell cycle at G1/S phase, S or G2/M phase so as to
provide sufficient time for repair of DNA damage [21,22]. If DNA
damage is not properly repaired, chromosomal deletions, duplications
or translocations can occur, thus TP53 protein will instantly activate
P21 (CDKN1A), BAX and other related genes to prevent gene
mutation and carcinogenesis [21,22,26-28]. In addition, TP53 is also
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connected to promoter binding of the oncogene C-MYC and inhibits
its transcription through promoting deacetylase [29]. Conversely, TP53
in the cytoplasm can directly act on pro-apoptotic BCL family
members to enhance transduction of apoptotic signals [10].
In this study, we focused on how PER2 is involved in DNA damage,
apoptosis and radiosensitivity of glioma cells induced by X-ray
irradiation. After comprehensively surveying the links between PER2
and TP53 in previous reports [2,4,9-15], we selected wild-type TP53
human U343 glioma cells, then RNA interference technology and
shRNA-lentivirus were used to downregulate PER2. However, we
found that following treatment with 6 mV, 100cGy of X-ray
irradiation, DNA damage was observed in both two groups after 24 h,
and shRNA-PER2-transfected cells showed more serious DNA tailing
phenomena and significantly increased death rate compared with
control cells. Following exposure to X-ray irradiation, U343 cells with
low PER2 expression levels had serious DNA damage and
ahigherdeath rate. We mainly focused on the mechanism by which
PER2 regulates the apoptosis of U343 cells through the ATM–TP53
pathway to initiate DNA damage repair. Unexpectedly, the important
checkpoint, ATM, in DNA damage should be activated a large number
when exposure to X-ray irradiation, then start the DNA repair system
mediated by TP53, to ensure maximum repair damaged DNA.
However, in our research, the expression of ATM was significantly
decreased in U343 cell with low PER2 expression levels when exposure
to X-ray irradiation, then causing a corresponding declined expression
of TP53. It shows that in addition to the effect of X-ray irradiation,
ATM also can be affected by other factors, such as PER2, in our
experiments, which play the most direct impact factor. We found that
ensuring other disturbing factors consistently, downregulation of the
expression of PER2 can decrease expression of activated ATM and
TP53. So we deem it not only involved in the regulation of DNA
damage, but regulated cell apoptosis by ATM-TP53 pathway as the
upstream gene of ATM and TP53.
These results indicated the important effect of PER2 in apoptosis of
U343 cells caused by irradiation: On the one hand, downregulation of
PER2 can enhance the radiosensitivity of U343 glioma cells, while
expression of important checkpoint in DNA damage, such as ATM,
was decreased by regulation of PER2, which reduced the effect of the
ATM–TP53 pathway activated by DNA damagecorresponding.
Moreover, C-MYC is also controlled by the circadian clock [30];
together with the two proteins described above, it can induce the
apoptosis of U343 cells.
Conclusions
In summary, it can be considered from our present study that
downregulation of PER2 can increase the sensitivity of U343 glioma
cells exposed to X-ray irradiation and promote apoptosis. The
mechanism by which it does this can be summarized as changes
expression of PER2, which can activate the ATM–TP53 pathway and
other genes associated with cell cycle arrest and apoptosis caused by X-
ray such as ATM, TP53 and C-MYC, thus further inducing apoptosis.
Therefore, we hypothesize that PER2, the core circadian gene, is not
only a tumor suppressor gene but can also be regarded as an upstream
regulatory gene of TP53, which plays an important role in inhibiting
tumor growth and promoting apoptosis of cancer cells by regulating
TP53 expression, DNA damage repair and apoptosis. These findings
provide a new target for the clinical treatment of glioma, and a reliable
basis for post-radiation therapy and gene therapy for glioma and other
cancers.
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